SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis

URL

https://www.sciencedirect.com/science/article/pii/S0168827822002343

Authors

Tobias Boettler, Benedikt Csernalabics, Henrike Salié, Hendrik Luxenburger, Lara Wischer, Elahe Salimi Alizei, Katharina Zoldan, Laurenz Krimmel, Peter Bronsert, Marius Schwabenland, Marco Prinz, Carolin Mogler, Christoph Neumann-Haefelin, Robert Thimme, Maike Hofmann, and Bertram Bengsch

Published Date

April 21, 2022

Publication

Journal of Hepatology

Organization

University of Freiburg (Germany)

Copyright Information

Medium

document

Topics

adverse events,COVID-19,vaccines